ArticlePDF AVAILABLE

Reassessing withholding of statins during Paxlovid therapy: Is it worth risking loss of the pleiotropic effects of statins and cardiovascular protection?

American Journal of Health-System Pharmacy
DOI: 10.1093/ajhp/zxad135
0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Author supplied keywords

Cite

CITATION STYLE

APA

Ariel, H., Ricupero, A., & Cooke, J. P. (2023, September 15). Reassessing withholding of statins during Paxlovid therapy: Is it worth risking loss of the pleiotropic effects of statins and cardiovascular protection? American Journal of Health-System Pharmacy. Oxford University Press. https://doi.org/10.1093/ajhp/zxad135

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free